Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocean Biomedical, Inc. - Common Stock (NQ: OCEA )

0.7290 +0.1341 (+22.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Ocean Biomedical, Inc. - Common Stock

Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END 
Via FinancialNewsMedia
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA
Via AB Newswire
Ocean Biomedical Inc. (NASDAQ: OCEA) Shares Promising Results on World Lung Cancer Day
Via Investor Brand Network
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
From FN Media Group LLC
Via GlobeNewswire
BioMedNewsBreaks – Ocean Biomedical Inc. (NASDAQ: OCEA) Shares Promising Results on World Lung Cancer Day
Via Investor Brand Network
BioMedNewsBreaks — Ocean Biomedical Inc. (NASDAQ: OCEA) Share Price Target Increased in FRC Report, Receives US Patent for Cancer Immunotherapy Treatment
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
BioMedNewsBreaks — Ocean Biomedical Inc. (NASDAQ: OCEA) Cofounder Issued Key US Patent for Bispecific Cancer Immunotherapy Treatment
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Ocean Biomedical (NASDAQ: OCEA) Receives U.S. Patent Approval Notice for New Malaria Treatment
Ocean Biomedical, Inc. (NASDAQ: OCEA) is engaged as a biopharmaceutical company, which is focused on the development and commercialization of 
Via Spotlight Growth
Topics Intellectual Property
Exposures Intellectual Property
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END 
Via FinancialNewsMedia
Ocean Biomedical (NASDAQ: OCEA) Skyrockets 324% After Announcing Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors Shown to Kill Glioblastoma & Melanoma Cancer Cells
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a Rhode Island-based biopharmaceutical company, which is focused on the development and commercialization of 
Via Spotlight Growth
BioMedNewsBreaks – Aesther Healthcare Acquisition Corp. and Ocean Biomedical Inc. (NASDAQ: OCEA) Announce Approved Business Combination
Via Investor Brand Network
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.